Grant: CEDARS-SINAI MEDICAL CENTER
Primary Recipient
CEDARS-SINAI MEDICAL CENTER
Amount
$591,999.00
Award Date
9/02/2009
Administering Agency
Health and Human Services, Department of / National Institutes of Health
CDFA Number
93.701
CDFA Program Title
Trans-NIH Recovery Act Research Support
Description
Diabetic retinopathy (DR) is the leading cause of blindness in people aged 20-74 years in the United States. Although retinopathy is more common in type 1 diabetes, the majority of new cases are due to type 2 diabetes (T2DM). The socioeconomic cost of DR
Vendors Connected to Award
Vendor | Role | Amount |
---|---|---|
Illumina Inc. | Primary vendor | $43,954.91 |
Illumina Inc. | Primary vendor | $284,472.00 |
Illumina Inc. | Primary vendor | $26,804.97 |